淋巴毒素
淋巴毒素β受体
细胞生物学
免疫系统
调解人
肿瘤坏死因子α
CTL公司*
生物
信号转导
免疫学
CD8型
作者
Steve W. Granger,Sandra Rickert
标识
DOI:10.1016/s1359-6101(03)00031-5
摘要
LIGHT is a tumor necrosis factor (TNF) superfamily ligand that regulates T cell immune responses by signaling through the herpes virus entry mediator (HVEM) and the lymphotoxin β receptor (LTβR). This review will present a summary of recent advances made regarding the immunobiology of the LIGHT–HVEM and LTβR systems. LIGHT has emerged as a potent initiator of T cell co-stimulation signals effecting CTL-mediated tumor rejection, allograft rejection and graft versus host disease. Constitutive expression of LIGHT leads to tissue destruction and autoimmune-like disease syndromes. In contrast to LTαβ, LIGHT plays a minimal role in lymphoid tissue development, yet some evidence indicates a role in negative selection in the thymus. These results provide an encouraging profile for the LIGHT–HVEM–LTβR axis as a potential target for controlling cellular immune reactions.
科研通智能强力驱动
Strongly Powered by AbleSci AI